| ID Source | ID |
|---|---|
| PubMed CID | 97817 |
| SCHEMBL ID | 348479 |
| MeSH ID | M0115284 |
| Synonym |
|---|
| nsc44104 |
| nsc-44104 |
| 2566-31-6 |
| di-n-propylglycine |
| dipropylglycine |
| AKOS000168812 |
| 2-amino-2-propylpentanoic acid |
| FT-0654905 |
| norvaline, 2-propyl- |
| alpha,alpha-di-n-propylglycine |
| nsc 44104 |
| SCHEMBL348479 |
| di-n-propylglycine (h-dpg-oh) |
| mfcd02092972 |
| 2-amino-2-n-propylvaleric acid |
| DTXSID80180359 |
| 2-amino-2-propyl-pentanoic acid |
| J-016093 |
| 2-propyl-dl-norvaline |
| CZHCGMZJLLOYJW-UHFFFAOYSA-N |
| CS-0205135 |
| PS-12768 |
| D87291 |
| norvaline,2-propyl- |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.21) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||